Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Feld

Showing results (381-390 of 451) with videos related to

Pageof 46
Sort By:
Gut|May 13, 2014
Reliable prediction of clinical outcome in patients with chronic HCV infection and compensated advanced hepatic fibrosis: a validated model using objective and readily available clinical parametersAdriaan J van der Meer, Bettina E Hansen, Giovanna Fattovich, et al.
The International Journal on Drug Policy|August 19, 2015
Recommendations for the management of hepatitis C virus infection among people who inject drugsJason Grebely, Geert Robaeys, Philip Bruggmann, et al.
The Journal of Clinical Investigation|April 15, 2025
Virus-associated inflammation imprints an inflammatory profile on monocyte-derived macrophages in the human liverJuan Diego Sanchez Vasquez, Shirin Nkongolo, Daniel Traum, et al.
JAMA|December 27, 2012
Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosisAdriaan J van der Meer, Bart J Veldt, Jordan J Feld, et al.
The International Journal on Drug Policy|February 6, 2016
Recommandations pour la prise en charge de l'infection par le virus de l'hépatite C chez les usagers de drogues par injectionJason Grebely, Geert Robaeys, Philip Bruggmann, et al.
Lancet Regional Health. Americas|May 21, 2026
Rapid hepatitis C test and treat with peer support at opioid treatment programs (RAPID HCV): a hybrid effectiveness-implementation type 1 randomized control trialOluwaseun Falade-Nwulia, Jennifer C Price, Jordan J Feld, et al.
Open Forum Infectious Diseases|July 2, 2026
Optimizing Hepatitis C Virus Antibody Testing Strategy and Setting: Results From a Large Real-World Screening ProgramGrishma Hirode, Camelia Capraru, Aaron Vanderhoff, et al.
The International Journal on Drug Policy|January 11, 2016
Empfehlungen zur Hepatitis Versorgung bei DrogenkonsumierendenJason Grebely, Geert Robaeys, Philip Bruggmann, et al.
The American Journal of Gastroenterology|September 1, 2021
High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal AdherencePhilippe J Zamor, Ashley Brown, Douglas E Dylla, et al.
Canadian Liver Journal|February 23, 2026
The 14th Canadian Symposium on Hepatitis C Virus: From research breakthroughs to equitable health care for priority populationsDaniel N Elakpa, David Lawton, Trinity H Tooley, et al.
Pageof 46

Showing results (381-390 of 451) with videos related to

Sort By:
Pageof 46
Gut|May 13, 2014
Reliable prediction of clinical outcome in patients with chronic HCV infection and compensated advanced hepatic fibrosis: a validated model using objective and readily available clinical parametersAdriaan J van der Meer, Bettina E Hansen, Giovanna Fattovich, et al.
The International Journal on Drug Policy|August 19, 2015
Recommendations for the management of hepatitis C virus infection among people who inject drugsJason Grebely, Geert Robaeys, Philip Bruggmann, et al.
The Journal of Clinical Investigation|April 15, 2025
Virus-associated inflammation imprints an inflammatory profile on monocyte-derived macrophages in the human liverJuan Diego Sanchez Vasquez, Shirin Nkongolo, Daniel Traum, et al.
JAMA|December 27, 2012
Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosisAdriaan J van der Meer, Bart J Veldt, Jordan J Feld, et al.
The International Journal on Drug Policy|February 6, 2016
Recommandations pour la prise en charge de l'infection par le virus de l'hépatite C chez les usagers de drogues par injectionJason Grebely, Geert Robaeys, Philip Bruggmann, et al.
Lancet Regional Health. Americas|May 21, 2026
Rapid hepatitis C test and treat with peer support at opioid treatment programs (RAPID HCV): a hybrid effectiveness-implementation type 1 randomized control trialOluwaseun Falade-Nwulia, Jennifer C Price, Jordan J Feld, et al.
Open Forum Infectious Diseases|July 2, 2026
Optimizing Hepatitis C Virus Antibody Testing Strategy and Setting: Results From a Large Real-World Screening ProgramGrishma Hirode, Camelia Capraru, Aaron Vanderhoff, et al.
The International Journal on Drug Policy|January 11, 2016
Empfehlungen zur Hepatitis Versorgung bei DrogenkonsumierendenJason Grebely, Geert Robaeys, Philip Bruggmann, et al.
The American Journal of Gastroenterology|September 1, 2021
High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal AdherencePhilippe J Zamor, Ashley Brown, Douglas E Dylla, et al.
Canadian Liver Journal|February 23, 2026
The 14th Canadian Symposium on Hepatitis C Virus: From research breakthroughs to equitable health care for priority populationsDaniel N Elakpa, David Lawton, Trinity H Tooley, et al.
Pageof 46